Alnylam Pharmaceuticals (ALNY) Q3 2015 Earnings

6AugConfirmed
Q4 2014
Q1 2015
Q2 2015
Q3 2015
-0.85
-0.66
-0.47
-0.28

Details

Expected EPS
-0.74
Actual EPS
-0.85
Surprise EPS
-0.11
Surprise Percent
+14.86%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.85 per share for Q3 2015.

0 Comments

Share your thoughts